RBFOX2 restrains oncogenic cell plasticity in Group 3 medulloblastoma
Rajiv Kumar Sah, Xinmiao Yan, Lexane Louis, Naomi M. Gonzales, Uyanga Tsogt, Baoqi He, Lily Greer Hoefner, Loïc LECOMTE, Mason D. Bartels, Charlotte A. Le Roux, Anne C Starner, Irene Basili, Olivier Ayrault, Eric L. Van Nostrand, Olivier Saulnier, , Tamra E. Werbowetski‐Ogilvie
This study identifies RBFOX2 as a suppressor of oncogenic cell plasticity in Group 3 medulloblastoma by regulating alternative splicing and cytoskeletal dynamics.
bioRxiv · Oct 6, 2026 · PreprintCancer Biology